Back to
Walleye Capital LLC
NGNE
Showing 6 of 9 quarters
Position history for
Walleye Capital LLC's holdings in NEUROGENE INC
No. Walleye Capital exited its NGNE (Neurogene) position in Q1 2026. Its Q4 2025 13F listed 36,102 shares worth $743,701. Walleye Capital first reported NGNE in Q4 2023 and held it in 7 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$1.9M
Total Shares Change
-44,500
Quarter-by-Quarter History